Immunyx Pharma

About

Funding history · 1 round · — total

Q&A

When was Immunyx Pharma founded?

Immunyx Pharma was founded in 2021.

What is Immunyx Pharma's primary focus?

Immunyx Pharma is a drug development company focused on modulating neutrophil function to treat diseases, using targeted nanoparticles to manipulate neutrophils for new therapies in conditions like COPD, cancer, colitis, and arthritis.

Which investors participated in Immunyx Pharma's Seed round?

In March 2021, Immunyx Pharma secured Seed funding from VLX Ventures.

Which investors participated in Immunyx Pharma's A Round?

In October 2021, Immunyx Pharma received A Round funding from Yissum and Hadasit.

Which investors participated in Immunyx Pharma's B Round?

In June 2023, Immunyx Pharma secured B Round funding from Yissum and Hadasit.

What is Immunyx Pharma's employee count as of August 2026?

As of August 2026, Immunyx Pharma has 6 employees.

Who are the co-founders of Immunyx Pharma?

The co-founders of Immunyx Pharma are Seth Salpeter (Co-Founder & CEO), Zvika Granot (Co-Founder & CSO), and Zvi Fridlender (Co-Founder & CMO).

What is Immunyx Pharma's affiliation with Johnson & Johnson Innovation - JLABS?

Immunyx Pharma is a Blue Knight company, which is a collaboration with Johnson & Johnson Innovation - JLABS.

What is Immunyx Pharma's affiliation with The Hebrew University?

Immunyx Pharma's technology is licensed from The Hebrew University, making it a spinout from the institution.

Team · 7

Seth Salpeter

Founder · Co-Founder & CEO

Zvika Granot

Founder · Co-Founder & CSO

Zvi Fridlender

Founder · Co-Founder & CMO

Meital Naim

Director of Pre-Clinical Development

Julian Adams

Director

Ori Choshen

Director

Moran Ben David

Director

Sectors & technology